Zobrazeno 1 - 10
of 142
pro vyhledávání: '"Etienne, Garin"'
Autor:
Jens M. Theysohn, Aydin Demircioglu, Malte Kleditzsch, Johannes M. Ludwig, Manuel Weber, Lale Umutlu, Yan Li, Malte Kircher, Constantin Lapa, Andreas Buck, Michael Koehler, Moritz Wildgruber, Christian M. Lange, Xavier Palard, Etienne Garin, Ken Herrmann, Michael Forsting, Felix Nensa
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract In cirrhotic patients with hepatocellular carcinoma (HCC), right-sided radioembolization (RE) with Yttrium-90-loaded microspheres is an established palliative therapy and can be considered a “curative intention” treatment when aiming for
Externí odkaz:
https://doaj.org/article/2bae8d44c17f47d0a5830705af79eda2
Autor:
Camille Goislard de Monsabert, Yann Touchefeu, Boris Guiu, Boris Campillo-Gimenez, Olivier Farges, David Tougeron, Isabelle Baumgaertner, Ahmet Ayav, Luc Beuzit, Marc Pracht, Astrid Lièvre, Samuel Le Sourd, Karim Boudjema, Yan Rolland, Etienne Garin, Eveline Boucher, Julien Edeline
Publikováno v:
Current Oncology, Vol 28, Iss 6, Pp 4530-4541 (2021)
Background: In the Yttrium-90 Microspheres in Cholangiocarcinoma (MISPHEC) single-arm phase 2 trial, concomitant chemotherapy and selective internal radiotherapy (SIRT) showed antitumor activity as a first-line treatment of unresectable intrahepatic
Externí odkaz:
https://doaj.org/article/b26145bb15414c43b17f1fd4757cc450
Autor:
Xavier Palard-Novello, Anne-Lise Blin, Florence Le Jeune, Etienne Garin, Pierre-Yves Salaün, Anne Devillers, Giulio Gambarota, Solène Querellou, Patrick Bourguet, Hervé Saint-Jalmes
Publikováno v:
EJNMMI Research, Vol 8, Iss 1, Pp 1-8 (2018)
Abstract Background Suboptimal temporal sampling of time-activity curves (TAC) from dynamic 18F-fluoromethylcholine (FCH) PET images may introduce bias in quantification of FCH uptake in prostate cancer assessment. We sought to define an optimal temp
Externí odkaz:
https://doaj.org/article/0182ee285c30456da62d2cdceb79593f
Publikováno v:
CardioVascular and Interventional Radiology. 45:1608-1621
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::923a9d5a078979ac48c520ab6646c882
https://doi.org/10.1007/s00270-022-03215-x
https://doi.org/10.1007/s00270-022-03215-x
Autor:
Nicolas Lepareur, Franck Lacœuille, Christelle Bouvry, François Hindré, Emmanuel Garcion, Michel Chérel, Nicolas Noiret, Etienne Garin, F. F. Russ Knapp
Publikováno v:
Frontiers in Medicine, Vol 6 (2019)
Rhenium-188 (188Re) is a high energy beta-emitting radioisotope with a short 16.9 h physical half-life, which has been shown to be a very attractive candidate for use in therapeutic nuclear medicine. The high beta emission has an average energy of 78
Externí odkaz:
https://doaj.org/article/83331741e4d649dcb836981949644ca0
Autor:
Etienne Garin, Xavier Palard, Yan Rolland, Samuel Le Sourd, Nicolas Lepareur, Valérie Ardisson, Christelle Bouvry, Sophie Laffont, Boris Campillo-Gimenez, Eric Bellissant, Julien Edeline
Publikováno v:
Cancers; Volume 15; Issue 8; Pages: 2245
Cancers
Cancers, 2023, 15 (8), pp.2245. ⟨10.3390/cancers15082245⟩
Cancers
Cancers, 2023, 15 (8), pp.2245. ⟨10.3390/cancers15082245⟩
International audience; Simple Summary Radioembolization is a kind of internal radiation therapy which is currently used in non-operable HCC. Several radiolabeled product can be used as Y-90-loaded microspheres or less frequently radiolabeled lipiodo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73c18bf81430382bbdaefda03b52113b
Autor:
Andrew Weaver, Steve Bandula, Ewan Brown, Alfonso Yubero Esteban, Philip Sinclair, Armeen Mahvash, Mary F. Mulcahy, Etienne Garin, Constantinos T. Sofocleous, William P. Harris, Paul Ross, Robert C.G. Martin, Amir H Montazeri, Siddharth A. Padia, Marc Pracht, Darryl Zuckerman, Ken Herrmann, Matthew S. Johnson, Gregory C. Wilson, Janet Graham, Riad Salem, Tae-You Kim, Robert J. Lewandowski, Jamie Mills
Publikováno v:
Journal of Clinical Oncology. 39:3897-3907
PURPOSE To study the impact of transarterial Yttrium-90 radioembolization (TARE) in combination with second-line systemic chemotherapy for colorectal liver metastases (CLM). METHODS In this international, multicenter, open-label phase III trial, pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6d03f73b0333d6da7b782768ee70fe2
https://doi.org/10.1200/jco.21.01839
https://doi.org/10.1200/jco.21.01839
Autor:
Etienne Garin, Yan Rolland, Luc Beuzit, Camille Goislard de Monsabert, Eveline Boucher, Astrid Lièvre, Yann Touchefeu, Samuel Le Sourd, David Tougeron, Karim Boudjema, Boris Campillo-Gimenez, Isabelle Baumgaertner, Olivier Farges, Ahmet Ayav, Marc Pracht, Julien Edeline, Boris Guiu
Publikováno v:
Current Oncology, Vol 28, Iss 384, Pp 4530-4541 (2021)
Current Oncology
Volume 28
Issue 6
Pages 384-4541
Current Oncology, MDPI, 2021, 28 (6), pp.4530-4541. ⟨10.3390/curroncol28060384⟩
Current Oncology, 2021, 28 (6), pp.4530-4541. ⟨10.3390/curroncol28060384⟩
Current Oncology
Volume 28
Issue 6
Pages 384-4541
Current Oncology, MDPI, 2021, 28 (6), pp.4530-4541. ⟨10.3390/curroncol28060384⟩
Current Oncology, 2021, 28 (6), pp.4530-4541. ⟨10.3390/curroncol28060384⟩
Background: In the Yttrium-90 Microspheres in Cholangiocarcinoma (MISPHEC) single-arm phase 2 trial, concomitant chemotherapy and selective internal radiotherapy (SIRT) showed antitumor activity as a first-line treatment of unresectable intrahepatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dca80d0413cb0ab31371dc1cb88ff5e4
https://www.mdpi.com/1718-7729/28/6/384
https://www.mdpi.com/1718-7729/28/6/384
Autor:
Helena Pereira, Mohamed Bouattour, Marco D. Burgio, Eric Assenat, Jules Grégory, Jean-Pierre Bronowicki, Gilles Chatellier, Valérie Vilgrain, Elisabeth Delhom-Christol, Marjolène Fourcade, Boris Guiu, Alina Diana Ilonca, Julie Lonjon, Georges-Philippe Pageaux, Mohamed Abdel-Rehim, Wassim Allaham, Laurent Castera, Arnaud Dieudonné, Rachida Lebtahi, Maxime Ronot, Annie Sibert, Hélène Chor, Julie Devictor, Hélène Barraud, Christophe Bazin, Laetitia Imbert, Valérie Laurent, Elodie Mathias, Carine Chagneau-Derrode, Christelle Gallais, Rémy Perdrisot, Christine Silvain, Jean Pierre Tasu, Patrick Borentain, Bardia Farman, René Gerolami, Olivier Mundler, Jean-Francois Seitz, Vincent Vidal, Christophe Aubé, Francis Bouchet, Antoine Bouvier, Olivier Couturier, Frédéric Oberti, Laurent Vervueren, Isabelle Brenot-Rossi, Julien Darreon, Jean Luc Raoul, Anthony Sarran, Julia Chalaye, Charlotte Costentin, Emmanuel Itti, Hicham Kobeiter, Alain Luciani, Hélène Masset, René Adam, Maïté Lewin, Didier Samuel, Julien Edeline, Etienne Garin, Sophie Laffont, Yan Rolland, Isabelle Archambeaud, Thomas Carlier, Thomas Eugene, Eric Frampas, Christophe Cassinotto, Martine Guyot, Jean-Baptiste Hiriart, Bruno Lapuyade, Karine Tendero, Julien Vergniol, Philippe Bachellier, Julien Détour, Bernard Duclos, Michel Greget, Francois Habersetzer, Alessio Imperiale, Elise Enderlin, Philippe Merle, Agnès Rode, Julie Morvan, Eric Nguyen-Khac, Antoine Talbot, Thierry Yzet, Guillaume Baudin, Patrick Chevallier, Abakar Mahamat, Fabien Maurel, Thierry Piche, Micheline Razzouk, Patrick Hillon, Romaric Loffroy, Michel Toubeau, Julie Vincent, Jean-Marc Vrigneaud, Gabriele Barabino, Nadia Bouarioua, Muriel Cuilleron, Marie Ecochard, Nathalie Prevot-Bitot, Evelyne Rousset, Vincent Leroy, Ghislaine Reboulet, Julie Roux, Christian Sengel, Valérie Bourcier, Nathalie Ganne-Carrie, Olivier Seror, Sylvie Costo, Thông Dao, Cédric Desmonts, Jean-Pierre Pelage, Didier Defez, Jérôme Dumortier, Francesco Giammarile, Pierre-Jean Valette, Michela Bernardini, Nadia Ghazar, Olivier Pellerin, Julien Taieb, Pierre Weinmann, Alexandra Heurgue-Berlot, Claude Marcus, Daniele Sommacale, Maria-Angéla Castilla-Lièvre, Aurélie Forbes, Sophie Maitre, Lysiane Marthey
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2021, 154, pp.46-56. ⟨10.1016/j.ejca.2021.05.032⟩
European Journal of Cancer, Elsevier, 2021, 154, pp.46-56. ⟨10.1016/j.ejca.2021.05.032⟩
Background The aim of this ancillary study of the SARAH trial is to compare health-related quality of life (HRQoL) in patients with locally advanced or inoperable hepatocellular carcinoma (HCC) treated with transarterial radioembolisation (TARE) or s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::813a4496fe7c63c5833e2c6c0dfdee24
https://doi.org/10.1016/j.ejca.2021.05.032
https://doi.org/10.1016/j.ejca.2021.05.032
Autor:
Eugénie Rigault, Laurence Lenoir, Guillaume Bouguen, Mael Pagenault, Astrid Lièvre, Etienne Garin, Laurent Siproudhis, Jean-François Bretagne
Publikováno v:
Endoscopy International Open, Vol 05, Iss 09, Pp E924-E930 (2017)
Background and study aims The relevance of incidental colorectal focal 18F-FDG PET/CT uptake is debatable. All patients who were referred for colonoscopy because of incidental colonic focal FDG uptake were included in this retrospective study. Patien
Externí odkaz:
https://doaj.org/article/c121e8b5d40e4d1890f1cf2211fcdfdf